Tenfovir disoproxil fumarate | Annual Sales Report | Pharmacompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Tenfovir Disoproxil Fumarate
Annual Reports

AMI Lifesciences is Driven by Chemistry. Powered by People.

Contact Supplier

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

Contact Supplier

Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

Contact Supplier

Quotient Sciences- Molecule to Cure. Fast.

Contact Supplier

pharmacompass-2-m-2025-08-25

Tenfovir disoproxil fumarate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

84 API Suppliers, 30 USDMF, 1 JDMF, 22 EU WC, 22 KDMF, 21 NDC API, 40 Listed Suppliers, $ API Reference Price

84 API Suppliers
30 USDMF
1 JDMF
22 EU WC
22 KDMF
21 NDC API
40 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

178 Drugs in Development

178 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

258 FDF Dossiers, 85 FDA Orange Book, 23 Europe, 32 Canada, 12 Australia, 89 South Africa, 17 Listed Dossiers

258 FDF Dossiers
85 FDA Orange Book
23 Europe
32 Canada
12 Australia
89 South Africa
17 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 200MG;EQ 25MG BASE;300MG, TABLET;ORAL - 150MG;150MG;200MG;300MG, TABLET;ORAL - 100MG;300MG;300MG, TABLET;ORAL - 300MG;300MG, TABLET;ORAL - 150MG, TABLET;ORAL - 200MG, TABLET;ORAL - 250MG, TABLET;ORAL - 300MG, TABLET;ORAL - 100MG;150MG, TABLET;ORAL - 133MG;200MG, TABLET;ORAL - 167MG;250MG, TABLET;ORAL - 200MG;300MG

TABLET;ORAL - 200MG;EQ 25MG BASE;300MG
TABLET;ORAL - 150MG;150MG;200MG;300MG
TABLET;ORAL - 100MG;300MG;300MG
TABLET;ORAL - 300MG;300MG
TABLET;ORAL - 150MG
TABLET;ORAL - 200MG
TABLET;ORAL - 250MG
TABLET;ORAL - 300MG
TABLET;ORAL - 100MG;150MG
TABLET;ORAL - 133MG;200MG
TABLET;ORAL - 167MG;250MG
TABLET;ORAL - 200MG;300MG

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 17 SPI Pharma, 6 DKSH, 8 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 2 Kirsch Pharma, 1 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 31 BASF, 1 Clariant, 11 Corel Pharma Chem, 5 DFE Pharma, 1 Esteem Industries, 1 Finar, 12 Gangwal Chemicals, 5 Ideal Cures, 4 Ingredion Pharma Solutions, 22 Kerry, 2 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 3 Pharmatrans-Sanaq, 7 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Roquette, 15 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 3 The Dow Chemical Company, 2 Ulanqab Kema New Material, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

72 Fillers, Diluents & Binders, 49 Coating Systems & Additives, 37 Direct Compression, 35 Disintegrants & Superdisintegrants, 33 Granulation, 29 Solubilizers, 28 Controlled & Modified Release, 25 Thickeners and Stabilizers, 20 Taste Masking, 20 Chewable & Orodispersible Aids, 19 Parenteral, 17 Topical, 16 Lubricants & Glidants, 15 Co-Processed Excipients, 14 Film Formers & Plasticizers, 8 Surfactant & Foaming Agents, 8 Emulsifying Agents, 7 API Stability Enhancers, 7 Rheology Modifiers, 5 Coloring Agents, 5 Empty Capsules, 4 Vegetarian Capsules

72 Fillers, Diluents & Binders
49 Coating Systems & Additives
37 Direct Compression
35 Disintegrants & Superdisintegrants
33 Granulation
29 Solubilizers
28 Controlled & Modified Release
25 Thickeners and Stabilizers
20 Taste Masking
20 Chewable & Orodispersible Aids
19 Parenteral
17 Topical
16 Lubricants & Glidants
15 Co-Processed Excipients
14 Film Formers & Plasticizers
8 Surfactant & Foaming Agents
8 Emulsifying Agents
7 API Stability Enhancers
7 Rheology Modifiers
5 Coloring Agents
5 Empty Capsules
4 Vegetarian Capsules

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 122 News #PharmaBuzz

1 Data Compilation #PharmaFlow
122 News #PharmaBuzz

GLOBAL SALES INFORMATION

24 US Medicaid Prescriptions, 17 Regulatory FDF Prices, 47 Annual Reports

24 US Medicaid Prescriptions
17 Regulatory FDF Prices
47 Annual Reports

MARKET PLACE

7 APIs, 6 FDF Dossiers

7 APIs
6 FDF Dossiers

PATENTS & EXCLUSIVITIES

22 US Patents, 2 US Exclusivities, 29 Health Canada Patents

22 US Patents
2 US Exclusivities
29 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 Others

4 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 152 Xls

Filters

Reset all filters

Filters

FILTER :

filter Product Reset all filters

47 All

01 5Atripla

02 1Complera

03 1Complera /Eviplera

04 7Complera/Eviplera

05 1Delstrigo

06 8Stribild

07 7Truvada

08 7Vemlidy

09 10Viread

List of Suppliers

Product Main Page

01

Brand Name : Stribild

Tenofovir Disoproxil Fumarate

Pharmaconex

Not Confirmed

Brand Name : Stribild

Pharmaconex

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Tenofovir Disoproxil Fumarate

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 196

2019 Revenue in Millions : 369

Growth (%) : -47

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Brand Name : Vemlidy

Tenofovir Disoproxil Fumarate

Pharmaconex

Not Confirmed

Brand Name : Vemlidy

Pharmaconex

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Tenofovir Disoproxil Fumarate

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 657

2019 Revenue in Millions : 488

Growth (%) : 35

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Brand Name : Complera/Eviplera

Tenofovir Disoproxil Fumarate

Pharmaconex

Not Confirmed

Brand Name : Complera/Eviplera

Pharmaconex

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Tenofovir Disoproxil Fumarate

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 269

2019 Revenue in Millions : 406

Growth (%) : -34

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Brand Name : Truvada

Tenofovir Disoproxil Fumarate

Pharmaconex

Not Confirmed

Brand Name : Truvada

Pharmaconex

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Tenofovir Disoproxil Fumarate

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 1,448

2019 Revenue in Millions : 2,813

Growth (%) : -49

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Brand Name : Viread

Tenofovir Disoproxil Fumarate

Pharmaconex

Not Confirmed

Brand Name : Viread

Pharmaconex

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Tenofovir Disoproxil Fumarate

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 185

2019 Revenue in Millions : 243

Growth (%) : -24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Brand Name : Atripla

Tenofovir Disoproxil Fumarate

CPHI Shenzhen

Not Confirmed

Brand Name : Atripla

CPHI Shenzhen

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Tenofovir Disoproxil Fumarate

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 349

2019 Revenue in Millions : 600

Growth (%) : -42

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Brand Name : Viread

Tenofovir Disoproxil Fumarate

Pharmaconex

Not Confirmed

Brand Name : Viread

Pharmaconex

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Tenofovir Disoproxil Fumarate

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2021 Revenue in Millions : 111

2020 Revenue in Millions : 185

Growth (%) : -40

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

Brand Name : Atripla

Tenofovir Disoproxil Fumarate

Pharmaconex

Not Confirmed

Brand Name : Atripla

Pharmaconex

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Tenofovir Disoproxil Fumarate

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2021 Revenue in Millions : 145

2020 Revenue in Millions : 349

Growth (%) : -58

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

Brand Name : Stribild

Tenofovir Disoproxil Fumarate

Pharmaconex

Not Confirmed

Brand Name : Stribild

Pharmaconex

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Tenofovir Disoproxil Fumarate

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2021 Revenue in Millions : 189

2020 Revenue in Millions : 196

Growth (%) : -4

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

Brand Name : Vemlidy

Tenofovir Disoproxil Fumarate

Pharmaconex

Not Confirmed

Brand Name : Vemlidy

Pharmaconex

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Tenofovir Disoproxil Fumarate

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2021 Revenue in Millions : 814

2020 Revenue in Millions : 657

Growth (%) : 24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3
Last

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!